LINK ALTERNATIF MBL77 NO FURTHER A MYSTERY

Not all sufferers with CLL require therapy. Regardless of all recent advancements, the iwCLL nonetheless endorses watchful observation for individuals with asymptomatic disease.86 This advice is predicated on a minimum of two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab